A/Professor Tim Sargeant | 2024 Sohn Hearts & Minds Conference

Associate Professor Tim Sargeant has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide where he studies the role of lysosomes in Alzheimer’s disease.

Read Transcript

Associate Professor Tim Sargeant earned his PhD from Victoria University of Wellington, New Zealand in 2008. He then undertook two postdoctoral roles at the University of Cambridge from 2008 until 2014. At Cambridge, his studies focussed on lysosomes, which are cellular structures that are essential for recycling damaged materials through a process known as autophagy.

‍

Since 2015, Tim has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide, Australia where he studies the role of lysosomes in Alzheimer’s disease. His work has revealed key connections between lysosomal function and Alzheimer’s disease, particularly the importance of autophagy in clearing build up of a protein called tau, which is a hallmark of the disease.

‍

Recently, Tim’s focus has shifted to developing tools for measuring human autophagy, with the goal of advancing this research towards preventing age-related diseases.

‍

You can watch his presentation from the 2024 Sohn Hearts & Minds Conference below.

‍

Posted

in

Impact

on

by

,

Hearts & Minds

Associate Professor Tim Sargeant earned his PhD from Victoria University of Wellington, New Zealand in 2008. He then undertook two postdoctoral roles at the University of Cambridge from 2008 until 2014. At Cambridge, his studies focussed on lysosomes, which are cellular structures that are essential for recycling damaged materials through a process known as autophagy.

‍

Since 2015, Tim has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide, Australia where he studies the role of lysosomes in Alzheimer’s disease. His work has revealed key connections between lysosomal function and Alzheimer’s disease, particularly the importance of autophagy in clearing build up of a protein called tau, which is a hallmark of the disease.

‍

Recently, Tim’s focus has shifted to developing tools for measuring human autophagy, with the goal of advancing this research towards preventing age-related diseases.

‍

You can watch his presentation from the 2024 Sohn Hearts & Minds Conference below.

‍

Disclaimer: This material has been prepared by Hearts & Minds, published on . HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook

November 22, 2019

Impact Video Series: Sydney Children's Hospital Foundation

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding.

Winning Hearts and Minds

Mark Nelson of Caledonia discusses his connection with the Florey Institute, one of our beneficiaries, and why he's involved with Hearts and Minds.

Understanding the 4 pillar framework underpinning a high conviction strategy

Listen to episode one with Chief Investment Officer Charlie Lanchester and TDM Growth Partners Investment Team Members Ed Cowan and Fraser Christie. They share their unique investment philosophies and delve into two high conviction stocks recommended for the HM1 portfolio.

No results found.

Please try a different search keyword or filter.